Proposed Rules Take Aim at Opioids, Compounded Drugs

The Ohio Bureau of Workers’ Compensation is proposing rules aimed at curbing spending on naloxone and compound drugs. The BWC would no longer approve reimbursement for naloxone auto-injectors, an opioid antidote that has soared in price in recent months, under the proposal. The rule would also require a 30-day trial with a commercially available, non-compounded topical medication before a compounded topical drug can be approved. Documentation would be required showing the non-compounded drug didn’t work or that the patient had an adverse reaction to it. And BWC would slash the m...